Cyclo Therapeutics, Inc. (CYTHW)

0.0320
0.00 (0.00%)
Inactive · Last trade price on Mar 25, 2025
-88.97%
Market Cap 20.73M
Revenue (ttm) 870,725
Net Income (ttm) -24.80M
Shares Out 28.77M
EPS (ttm) -0.92
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 28,412
Open 0.0697
Previous Close 0.0320
Day's Range 0.0320 - 0.0320
52-Week Range 0.0250 - 0.6140
Beta -0.57
Analysts n/a
Price Target n/a
Earnings Date Mar 19, 2025

About CYTHW

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company’s lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer’s disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, prim... [Read more]

Sector Healthcare
Founded 1990
Employees 8
Stock Exchange NASDAQ
Ticker Symbol CYTHW
Full Company Profile

News

There is no news available yet.